Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
When index levels rise, adjust allocations gradually and monitor sectors leading the move. This intro provides simple steps to respond without overreacting.
19,220 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A New Mexico jury awarded Meta $375 million in a landmark ruling over child-safety claims, challenging broad protecti...
A proposed state ban on institutional buyers could change how Californians get loans for homes and how lenders price ...
XRP strengthens on both USD and BTC markets as momentum turns bullish, crossing key thresholds and drawing investor a...
Eight years, 25 properties, 35 units. This is the real-world story behind deal diaries: cameron philgreen, a Texas in...
Bitcoin broke below a key support zone and is hovering near a $70K-$72K confluence as ETF demand wanes and bears stay...
Brent crude sits around $101 per barrel on June 3, 2026, as markets weigh supply risks, demand patterns, and policy m...
Retirees are eyeing Mississippi as a low-cost option to make your retirement budget go further, but savings vary by c...
Investors face a decisive choice: lean into specialized aerospace parts with HEICO or embrace Textron’s diversified i...
Costco stock sits near the $1,000 level as the retailer’s membership model and growing online business fuel growth. A...
A top research firm issues the highest conviction call realty on Realty Income, setting a bold price target as the RE...
Oil prices slide to the low $70s as Middle East risk cools, fueling debates on whether the Federal Reserve has paused...